Welcome to our dedicated page for ZIMVIE SEC filings (Ticker: ZIMV), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
This page provides access to historical SEC filings for ZimVie Inc. (formerly Nasdaq: ZIMV), which reported itself as a global life sciences leader in the dental and dental implant market. While ZimVie was a public company, it filed current reports, periodic reports, and proxy materials with the U.S. Securities and Exchange Commission that documented its financial performance, corporate actions, and the details of its acquisition by an affiliate of ARCHIMED.
Key filing types for ZimVie include Form 8-K current reports describing material events. For example, a July 21, 2025 Form 8-K outlines the Agreement and Plan of Merger with Zamboni Parent Inc. and Zamboni MergerCo Inc., an affiliate of ARCHIMED, including the cash consideration per share and the conditions to closing. Subsequent 8-K filings on October 3 and October 10, 2025 provide information on supplemental proxy disclosures, stockholder litigation related to the proxy statement, and the results of the special meeting at which stockholders voted to adopt the merger agreement.
Another Form 8-K dated July 30, 2025 incorporates a press release reporting financial results for the quarter ended June 30, 2025. This filing discusses net sales from continuing operations, net loss from continuing operations, adjusted EBITDA, and adjusted diluted earnings per share, and explains the use of non-GAAP financial measures and constant currency sales metrics. Earlier filings and related documents, such as annual reports on Form 10-K and quarterly reports on Form 10-Q referenced in company news releases, contain more detailed financial statements, risk factors, and management’s discussion and analysis.
Filings around the merger also describe the expected delisting and deregistration of ZimVie’s common stock. The October 10, 2025 Form 8-K notes that, upon completion of the merger, the company would no longer be publicly held, and its common stock would be delisted from the Nasdaq Global Select Market and deregistered under the Securities Exchange Act of 1934. A later company press release confirms that, after the closing of the transaction on October 20, 2025, ZimVie became a privately held company and its stock ceased trading on Nasdaq.
On this page, users can review these historical filings to trace ZimVie’s regulatory history, including its financial reporting practices, the structure and terms of the ARCHIMED acquisition, and disclosures related to stockholder litigation and proxy processes. AI-powered summaries can help explain the main points of each filing, highlight important sections in lengthy documents, and make it easier to understand how ZimVie’s public-company obligations evolved up to its transition to private ownership.